我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

CTRP6与冠状动脉慢血流的相关性及其可能机制

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第5期
页码:
596-599
栏目:
临床研究
出版日期:
2015-05-05

文章信息/Info

Title:
CTRP6 is associated with coronary slow flow
作者:
张 昕1; 衡 亮2; 刘 军1; 任引刚1; 高砚丽1; 张利华1
（第四军医大学唐都医院:1.老年病科，2.门诊部，陕西 西安 710038）
Author(s):
ZHANG Xin1;  HENG Liang2;  LIU Jun1;  REN Yin-gang1;  GAO Yan-li1;  ZHANG Li-hua1
(1.Department of Geriatrics, 2.Out Patient Department, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, Shaanxi, China)
关键词:
冠状动脉慢血流; c1q肿瘤坏死因子相关蛋白6; 内皮祖细胞; 内皮素1; 基质金属蛋白酶2
Keywords:
coronary slow flow;  c1q tumor necrosis factor-related protein 6;  endothelial progenitor cells;  endothelin-1;  matrix metalloproteinase-2
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的 研究冠状动脉慢血流（CSF）现象与C1q肿瘤坏死因子相关蛋白6（CTRP6）的相关性，并初步探讨CTRP6影响CSF的潜在分子机制。方法 CSF组患者42例,正常血流组（对照组）45 例。根据校正的TIMI血流计帧法（cTFC）计算各支冠状动脉的TIMI帧数，采用生化法测定血清中CTRP6的含量。然后随机抽取6位CSF患者取外周血，分离培养其内皮祖细胞（EPCs），分别转染CTRP6的过表达载体pcDNA-CTRP6，3 d后用DdU法检测EPCs细胞增殖对EPCs进行计数，并检测转染前后转染组和对照组的培养基中CSF相关因子基质金属蛋白酶（MMP）-2和内皮素（ET）-1的分泌量变化。结果 CSF组的CTRP6水平显著低于对照组〔(1.2±0.5) vs.(2.7±1.0)〕 mg/L，P<0.01，Logistic回归分析表明血清CTRP6含量与CSF患者的cTFC呈负相关（β=-1.76），CTRP6是CSF的保护因素（OR=0.395）；EPCs中过表达CTRP6引起EPCs数目显著上升（P<0.05），CSF负相关因子MMP-2水平被显著上调（P<0.01），正相关因子ET-1水平被显著下调（P<0.05）。结论 CSF组血清CTRP6水平低，血清CTRP6含量与CSF患者的cTFC呈负相关；CTRP6能够促进MMP-2和降低ET-1的分泌。
Abstract:
AIM To study the association between coronary slow flow (CSF) phenomenon and C1q tumor necrosis factor-related protein 6 (CTRP6), and to explore the potential molecular mechanism of CTRP6 impact on CSF. METHODS Each coronary artery blood flow TIMI frame was calculated using corrected TIMI frame count method (cTFC) in CSF group (n=42) and normal control group (n=45), and c1q tumor necrosis factor-related protein 6 in serum was determined using biochemical methods. Then, six CSF patients were randomly selected to phlebotomize peripheral blood, which was used to isolate and culture endothelial progenitor cells (EPCs). EPCs were transfected with pcDNA-CTRP6 overexpression vector. After 3 days, cell proliferation was detected using EdU method and the number of the cells was counted by an automated cell instrument. Finally, the secretion levels of CSF-related factors matrix metalloproteinase 2 (MMP-2) and endothelin-1 (ET-1) were examined and compared. RESULTS CTRP6 levels in CSF group were significantly lower than in control group ［(1.2±0.5) vs.( 2.7±1.0) mg/L, P=0.002］. Logistic regression analysis showed that serum CTRP6 and cTFC content in CSF patients were negatively correlated (β=-1.76), and CTRP6 was a protective factor for CSF (OR=0.395). Moreover, CTRP6 overexpression resulted in a significant increase of EPC number (P<0.05). The secretion levels of MMP-2 were negatively correlated with CSF and were significantly upregulated (P<0.01). Levels of ET-1 positively correlated with CSF were significantly downregulated (P<0.05). CONCLUSION Serum CTRP6 level is lower and is negatively correlated with cTFC content in CSF patients. Serum CTRP6 is a protective factor for CSF and promotes MMP-2 and reduces ET-1 secretion.

参考文献/References

[1]Mangieri E,Macchiarelli G,Ciavolella M,et al.Slow coronary flow:clinical and histopathological features in patients with otherwise normal epicardial coronary arteries[J].Cathet Cardiovasc Diagn,1996,37(4):375-381.
[2]Tambe A,Demany M,Zimmerman HA,et al.Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding[J].AHJ,1972,84(1):66-71.
[3]Beltrame JF,Limaye SB,Horowitz JD.The coronary slow flow phenomenon-a new coronary microvascular disorder[J].Cardiology,2002,97(4):197-202.
[4]Beltrame JF,Limaye SB,Wuttke RD,et al.Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon[J].AHJ,2003,146(1):84-90.
[5]Li JJ,Qin XW,Li ZC,et al.Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow[J].Clin Chim Acta,2007,385(1):43-47.
[6]Ward MR,Pasterkamp G,Yeung AC,et al.Arterial remodeling mechanisms and clinical implications[J]. Circulation,2000,102(10):1186-1191.
[7]Godin D,Ivan E,Johnson C,et al.Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model[J].Circulation, 2000,102(23):2861-2866.
[8]Barutcu I,Sezgin AT,Sezgin N,et al.Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow[J].Angiology,2007,58(4):401-407.
[9]Selcuk H,Selcuk MT,Temizhan A,et al.Decreased plasma concentrations of adiponectin in patients with slow coronary flow[J].Heart Vessels,2009,24(1):1-7.
[10]Camsarl A,Pekdemir H,Cicek D,et al.Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow[J].Circ J,2003,67(12):1022-1028.
[11]Pekdemir H,Polat G,Cin VG,et al.Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow[J].Int J Cardiol,2004,97(1):35-41.
[12]Zheng Q,Yuan Y,Yi W,et al.C1q/TNF-related proteins,a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway[J].Arterioscler Thromb Vasc Biol,2011,31(11):2616-2623.
[13]Sch?ffler A,Buechler C.CTRP family:linking immunity to metabolism[J].Trends Endocrin Met,2012,23(4):194-204.
[14]Choi KM,Hwang SY,Hong HC,et al.Implications of C1q/TNF-related protein-3(CTRP-3)and progranulin in patients with acute coronary syndrome and stable angina pectoris[J].Cardiovasc Diabetol,2014,13(1):14.
[15]Young PP,Hofling AA,Sands MS.VEGF increases engraftment of bone marrow-derived endothelial progenitor cells(EPCs)into vasculature of newborn murine recipients[J].Proc Natl Acad Sci U S A,2002,99(18):11951-11956.

备注/Memo

备注/Memo:
收稿日期：2014-12-11.
通讯作者：张利华，主任医师，主要从事高血压病和冠状动脉介入治疗研究 Email：zlh1204@sohu.com
作者简介：张昕，硕士生 Email：14925181@qq.com
更新日期/Last Update: 2015-04-28